M
yosin VIIA is a member of the myosin superfamily. The mutant gene of myosin VIIA is responsible for human Usher syndrome type 1B (1) and two forms of nonsyndromic deafness, DFNB2 and DFNA11 (2) (3) (4) . The heavy chain of this myosin has several structural characteristics. The N-terminal domain is a conserved motor domain followed by the neck domain containing five IQ motifs that binds light chains. The tail domain consists of a proximal segment of short predicted coiled-coil domain followed by a globular domain. Because of the presence of the coiled-coil domain, it was originally assumed that myosin VIIA exists as a dimer, i.e., a two-headed structure. However, recent biochemical and structural studies have revealed that myosin VIIA is a monomer (5, 6) . The globular tail domain contains two large repeats, each incorporating a myosin tail homology 4 (MyTH4) domain and a band 4.1, ezrin, radixin, moesin (FERM) domain (7) (Fig. S1 ).
Myosin VIIA function is best studied in sensory organs. Myosin VIIA is found in two retinal cell types: the photoreceptor cells and the pigmented epithelial (RPE) cells (8, 9) . Melanosomes in RPE cells undergo light cycle-dependent movement. After light onset, there was a significant increase in the number of melanosomes in the apical processes, and it is suggested that myosin VIIA is required for the proper movement of melanosome transportation (10) .
A critical question is how the cargo-transporting activity can be regulated in cells. Because the tail domain is assumed to be the cargo-binding domain, we hypothesized that the myosin VIIA targeting molecules can serve as regulators of the myosin VIIA function. Among various myosin VIIA targeting molecules, the role of MyRip in melanosome transport has been best studied. In RPE cells, myosin VIIA, MyRip, and Rab27a are associated with melanosomes and motile small vesicles (11) , suggesting that the ternary complex may function in melanosome motility.
In the present study, we observed the translocation of myosin VIIA and its cargos to the tip of filopodia and found that myosin VIIA is predominantly monomeric in cells, and it translocates to filopodial tips with its cargo molecule upon dimer formation. The cargo molecules, MyRip/Rab27a, induced the translocation of the wild-type myosin VIIA to the filopodial tips, suggesting that the cargo molecules play a critical role in activating myosin VIIA as a cargo transporter.
Results
Human Myosin VIIA Translocates to the Tip of Filopodia upon Dimer Formation. Recent studies have shown that Drosophila myosin VIIA is a monomeric (single-headed) myosin (5, 6) . To examine whether human myosin VIIA in cells is predominantly monomer or dimer, we expressed the headless human myosin VIIA in cells from a spontaneously arising human RPE cell line, ARPE-19, and dimer formation was studied by using chemical cross-linking as a probe for dimer formation. As shown in Fig. 1A , M7SAHcoilTail, containing its endogenous short predicted coiled-coil region, could not be crosslinked. By contrast, dimer formation was efficiently demonstrated for M7SAHcoilTail with a leucine zipper motif (LZ-M7SAHcoil-Tail), forcing dimer production. We generated human myosin VIIA heavy meromyosin (M7HMM) constructs with a C-terminal FK506 binding protein (FKBP) that conditionally forms homodimers upon addition of the dimer-inducing drug AP20187 (12) . This construct was efficiently cross-linked into the high-molecular-mass dimer only when the cells were incubated with AP20187 (Fig. 1B) . As expected, dimers were similarly observed when the leucine zipper motif was added to the C-terminal end of M7HMM (M7HMM-LZ) (Fig. 1B) . We also observed that endogenous myosin VIIA of ARPE-19 cells was not cross-linked, whereas myosin IIB in the cells was crosslinked to form a dimer (Fig. 1C) . These results suggest that human myosin VIIA does not form a stable dimer in cells. It was reported previously that Drosophila myosin VIIA is a high duty ratio motor suitable for a processive movement (13) , and the forced dimer of the tail-truncated Drosophila myosin VIIA can move processively in vitro (14) . Therefore, we asked whether human myosin VIIA may move on actin filaments in vivo once it forms a dimer. As shown in Fig. 1D , we found that GFP-M7HMM-LZ, but not GFP-M7HMM without the leucine zipper, localized at the tip of filopodia. These results suggest that the GFP-M7HMM moves on actin-filament bundles within filopodia to the tip only when it forms a dimer.
To further address this notion, we used a drug-induced dimerization technique that we have described previously (12) . The
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1009188108/-/DCSupplemental. movement of GFP-M7HMM-FKBP in living HeLa cells was monitored under the confocal epifluorescence microscope. GFP-M7HMM-FKBP was distributed throughout the cell body before addition of the homodimerizer, AP20187 (Fig. 1E Left) . However, after the addition of AP20187, GFP signals became progressively concentrated at the tip of filopodia over time ( Fig. 1E Right and Movie S1). These results further support the notion that dimer formation is critical for the movement of myosin VIIA to the tip of filopodia. It should be noted that the overexpression of GFP-M7HMM-FKBP did not induce filopodia/microspike formation after the addition of AP20187 (Fig. S2) , unlike myosin X (12, 15) . In 3D images from confocal optical slices (Fig. S3) , we found that GFP-M7HMM-FKBP also translocated toward the tip of apical filopodia. These results suggest that dimer formation is critical for the movement of myosin VIIA to filopodial tips of both substrateattached and -nonattached apical filopodia.
Motor Activity and a Proper Neck Length Are Required for the Translocation of Myosin VIIA to the Tip of Filopodia. To see whether the translocation of GFP-myosin VIIA to the tip of filopodia is driven by the motor activity of myosin VIIA or by other mechanisms, we produced myosin VIIA constructs having an FKBP module, in which the residues critical for the motor activity are mutated (Fig. S4A) . Three mutants were made: R212A, G440A, and G25R. The mutation of conserved R212 in Switch-1, which is critical for ATP binding, is expected to disrupt proper ATPinduced dissociation of myosin from actin upon ATP binding (16, 17) . The conserved G440 is in the Switch-2 region, and the G440A mutation disrupts ATP hydrolysis but not the ATP bindinginduced dissociation of myosin from actin (16, 18) . On the other hand, the mutation of G25 (19) , which is unique in myosin VII, inhibits the actin-activated ATPase activity of myosin VIIA (19) . All three mutants failed to allow the translocation of GFP-M7HMM-FKBP to the tip of filopodia upon addition of AP20187. These results indicate that the translocation of GFP-M7HMM to the tips is driven by its own motor activity. Because dimer formation is critical for tip translocation, we suggest that the processive movement of myosin VIIA within filopodia is critical for tip translocation.
It has been thought that the neck length, or lever-arm length, may be important for the processive movement of myosin Va (20) (21) (22) (23) (24) (25) , myosin VI (26) (27) (28) , and myosin X (12) . Therefore, we examined whether the proximal tail domains, including the short coiled-coil and single α-helix (SAH) domains, are important for tip translocation of myosin VIIA. These domains may contribute to the lever-arm length. When we sequentially deleted two proximal tail domains, i.e., the coiled-coil and SAH domains, we found that, although the coiled-coil domain was dispensable for tip translocation, further truncation of the SAH domain abolished the translocation of GFP-M7HMM-FKBP (Fig. S4B) . These results suggest that the SAH domain is important for the continuous movement of myosin VIIA within filopodia. Myosin VIIA has a long neck with five IQ motifs, similar to myosin Va with six IQ motifs, but our result suggests that the long IQ domain of myosin VIIA is not sufficient for processive movement.
Myosin VIIA Transports MyRip to the Tip of Filopodia upon Dimer Formation. To determine whether myosin VIIA can function as a cargo transporter, we cotransfected HeLa cells with GFP-myosin VIIA and mCherry-MyRip, a myosin VIIA binding protein (29, 30) . GFP-M7HMMΔcoil-FKBP-tail, having the cargo-binding tail domain, showed diffuse localization before the addition of AP20187 (Fig. S5A ), but it translocated to filopodial tips after the addition of the dimer inducer (Fig. S5B ). On the other hand, mCherry-MyRip, showing diffuse localization before the addition of AP20187, translocated to filopodial tips after addition of AP20187 (Figs. S5B and S6). The transportation of MyRip required the tail domain of myosin VIIA because GFP-M7HMM-FKBP failed to transport mCherry-MyRip to the tip upon addition of AP20187, although it translocated to the tip upon the addition of AP20187 (Fig. S5C ). However, in the absence of an FKBP or leucine zipper dimerization domain, GFP-M7Full was unable to cotransport mCherry-MyRip to the filopodial tips (Fig. S5D) . These results suggest that a full-length myosin VIIA, once dimerized, can transport MyRip.
Myosin VIIA and MyRip Cotransported to the Filopodial Tips in ARPE-19 Cells. It has been suggested that myosin VIIA is present in RPE cells and may play an important role in transportation of melanosomes (10, 11, 16, 31) . Using the RPE-derived cell line ARPE-19, we studied the translocation of myosin VIIA and its cargo molecule, MyRip. Expressed by itself, GFP-M7Full showed diffuse localization with no obvious tip localization ( Fig. 2A) . Quite interestingly, coexpression of mCherry-MyRip with GFP-M7Full induced the localization of both proteins to filopodial tips in cells ( Fig. 2 B and E). Filopodial tip localization of GFP-M7Full was markedly increased from 4.3 ± 1.0% to 56 ± 5% by coexpression of mCherry-MyRip ( express endogenous myosin VIIA. On the other hand, endogenous MyRip was not detected by Western blotting using anti-MyRip antibodies, which recognized GFP-MyRip expressed in transfected ARPE-19 cells. Therefore, we examined whether MyRip also induces the translocation of endogenous myosin VIIA. Expression of GFP-MyRip caused the filopodial tip localization of endogenous myosin VIIA along with GFP-MyRip (Fig. 2C) , whereas filopodial tip localization of endogenous myosin VIIA was not observed in the absence of MyRip expression (Fig. 2D) .
MyRip is known to associate with Rab27a, which binds to lipid vesicles with its geranyl-geranyl moiety (29, 30) . We next asked whether Rab27a is also transported to filopodial tips along with MyRip. The cells were transfected with three constructs: GFPM7Full, mCherry-MyRip, and myc-Rab27a. The triple transfection revealed that Rab27a was cotransported with myosin VIIA and MyRip to the tips of filopodia (Fig. 3A) . Filopodial tip localization of GFP-M7Full was significantly increased from 5.5 ± 2.1% to 43.9 ± 5.7% by coexpression of mCherry-MyRip (Fig. 3C) . The tip localization of myc-Rab27a required mCherryMyRip (Fig. 3B) , suggesting that MyRip bridges an association between myosin VIIA and Rab27a. The critical finding is that full-length myosin VIIA translocated to the tip of filopodia in the presence, but not in the absence, of MyRip. Because dimer formation is required for the filopodial tip localization of myosin VIIA, the results also suggest that the binding of MyRip may induce the dimer formation of myosin VIIA.
MyRip Facilitates Association of Myosin VIIA to Vesicles and Promotes
Dimer Formation. Because a myosin VIIA forced dimer, but not monomer, translocates to the filopodial tips, we hypothesized that the role of MyRip is to facilitate myosin VIIA association to membrane vesicles through Rab27a, which subsequently induces myosin VIIA dimer formation.
To evaluate this idea, we cotransfected MyRip and myosin VIIA tail in ARPE-19 cells. The cell lysates were subjected to cell fractionation. Separation of each fraction was confirmed by using the specific marker protein antibodies (Fig. 4A) . The amount of myosin VIIA tail associated with membrane vesicle notably increased in the cells cotransfected mCherry-MyRip (Fig. 4B) . The increase in the membrane-vesicle association in the presence of MyRip was calculated by considering the cotransfection efficiency (86 ± 3.5%, n = 4). We found that the membrane-vesicle association of myosin VIIA tail was significantly increased by 2.8 ± 0.6-fold in the presence of MyRip (P value of 0.0067 < 0.01 by paired t test) (Fig. 4C) .
Next, we examined the effect of MyRip expression on myosin VIIA dimer formation by using a chemical cross-linking technique. As shown in Fig. 4D , the coexpression of MyRip produces cross-linked dimers of M7SAHcoilTail, in contrast to the expression of M7SAHcoilTail alone. The amount of the crosslinked dimer increased by 3.3 ± 0.4-fold in the presence of MyRip, considering the transfection efficiency (P value of 0.0065 < 0.01 by paired t test) (Fig. 4E) . It should be noted that the amount of the cross-linked product of M7SAHcoilTail was much lower than that of LZ-M7SAHcoilTail, which contained the leucine zipper. We think that a significant fraction of M7SAHcoilTail in the cotransfected cells is monomeric even in the presence of GFPMyRip, in part because only a part of M7SAHcoilTail associates with MyRip/Rab27a complex. Supporting this view, we found that the amount of myosin VIIA tail in cytosol was much higher than that associated with vesicles, which represented myosin VIIA fraction associated with MyRip/Rab27a (Fig. 4B ). The present results strongly suggest that the binding of MyRip to myosin VIIA induces the association of myosin VIIA to membrane vesicles and myosin VIIA dimer formation in ARPE-19 cells.
Elimination of Myosin VIIA/MyRip Interaction or MyRip/Rab27a
Interaction Hampers Myosin VIIA Translocation to Filopodial Tips.
The present results suggest that the formation of myosin VIIA/ MyRip/Rab27a complex and its association with membrane vesicles is critical for myosin VIIA movement to the filopodial tips. To further evaluate this idea, we produced several deletion constructs of MyRip and Rab27a in which the domains critical to the attachment of myosin VIIA to membrane vesicles were eliminated. The effect of deletion on the translocation of myosin VIIA to the tip of filopodia was subsequently examined. The deletion of the Cterminal MyTH4 and FERM domain of myosin VIIA, the MyRip binding domain, diminished the translocation of myosin VIIA to the tip (Fig. 5 A and D) . The deletion of the Fyve domain in MyRip, which serves as a Rab27a binding but not myosin VIIA binding site (29, 30) , also hampered the tip localization of both myosin VIIA and MyRip (Fig. 5 B and D) . These results further support the idea that the membrane targeting of myosin VIIA is critical for the movement of the myosin VIIA/cargo complex. On the other hand, the deletion of the short putative coiled-coil domain slightly decreased the tip localization of myosin VIIA (Fig. 5 C and D) (P value of 0.003 < 0.01 by paired t test).
Discussion
Previous in vitro studies of Drosophila myosin VIIA have suggested that myosin VIIA can be a cargo-transporting motor because it is a high duty ratio motor (13) and the forced dimer construct of the tail-truncated Drosophila myosin VIIA moves processively in vitro (14) . In the present study, we showed that human myosin VIIA can transport its cargo complex in ARPE-19 cells, thus functioning as a cargo transporter. Human myosin VIIA by itself showed diffuse localization, suggesting that myosin VIIA may not continuously move along actin structures toward the specific destination, such as filopodial tips, by itself in cells.
The critical finding of the present study is that myosin VIIA moves cargoes to the tip of filopodia when it is forced to dimerize. The question is whether the wild-type full-length myosin VIIA, which is monomeric in vitro, can serve as a cargo transporter in cells. Although the wild-type full-length myosin VIIA did not localize at the filopodial tips, expression of MyRip in ARPE-19 cells induced the translocation of myosin VIIA along with MyRip ( Fig. 2 B and C) . Myosin VIIA, MyRip, and Rab27a are colocalized at the tip of filopodia (Fig. 3A) , suggesting that myosin VIIA transports them after becoming activated by the binding to its cargo molecule complex. Because Rab27a associates with membrane vesicles with its geranyl-geranyl moiety, it is thought that the MyRip/Rab27a complex links myosin VIIA to membrane vesicles, such as premature melanosomes, in ARPE-19 cells. It should be noted that, although ARPE-19 cells do not make mature melanosomes containing melanin (32) , Rab27a is present at stages of melanosome maturation (33) , which facilitates the translocation of myosin VIIA/cargo complex to the filopodial tips. Because a myosin VIIA forced dimer, but not monomer, can move toward filopodial tips, it is reasonable to assume that the production of myosin VIIA/MyRip/Rab27a ternary complex and its association with membrane vesicles induces dimer formation, thus activating the movement of myosin VIIA/cargo complex in cells. Supporting this view, we found that MyRip promotes membrane-vesicle association and dimer formation of myosin VIIA tail in ARPE-19 cells (Fig. 4) . Because the production of a ternary complex is critical for myosin VIIA/cargo complex translocation, these results support the idea that the membrane targeting of myosin VIIA induces the cluster formation on the membrane, which facilitates possible dimer formation, which is critical for continuous movement of myosin VIIA and the activation of myosin VIIA as a cargo transporter to mediate trafficking of the melanosome/Rab27a/ MyRip cargo complex.
Based on the present results, we propose the following model for the regulation of cargo transportation by myosin VIIA. Motor activity of myosin VIIA is inhibited before the binding of its cargo complex, and myosin VIIA binds to the adaptor molecules MyRip and Rab27a. The binding to the adaptor molecules facilitates the association of myosin VIIA with membrane vesicles. Myosin VIIA monomers on membrane vesicles move laterally on the membrane and encounter each other to form a cluster of molecules, which may induce dimer formation, and the movement is activated. Alternatively, formation of a cluster of molecules may be sufficient to support continuous movement of the vesicles. Recently, it was reported that a cluster of four myosin VI molecules on a nanosphere can move the nanosphere processively on actin structure of the permeabilized cells (34) . On the other hand, it has been thought that the motility of the KIF1/Unc-104 class of kinesin may be regulated by reversible monomer-dimer transition (35) . Although Unc-104 in solution is monomeric, it has been suggested that the neck-linker undocking or saturation of microtubules with Unc-104 induces dimer formation (36, 37) . Tomishige et al. showed that rapid processive motility of Unc-104 is observed only when the motor is artificially dimerized (38) . In the case of Unc-104, the processive movement of a dimer cannot be substituted by a clustering of monomers. Further studies are required whether the dimer formation is absolutely necessary for cargo transportation by myosin VIIA.
For myosin VI, cargo proteins, such as Dab2 and optineurin, directly induced myosin VI dimer (39) . The tail domain of myosin VI binds to the 39-residue fragment of the vesicle adaptor Dab2, which induces dimerization of the tail/Dab2 peptide complex (40) . In the present study, it is suggested that, unlike myosin VI/ Dab2 binding, the binding of the targeting molecule, MyRip, does not directly promote dimer formation. These results suggest that, although dimer formation is important for the cargo-transporting function of motor proteins, the regulatory mechanisms of dimer formation and, more importantly, the cargo-transporting function of motor proteins is different from each other.
The function of the predicted short coiled-coil domain is obscure. The deletion of this domain did not largely diminish the tip localization of myosin VIIA when MyRip was coexpressed in ARPE-19 cells (Fig. 5 C and D) , and this region may not contribute to the dimer formation. This region also is not required for the motility activity of myosin VIIA itself because the deletion of this region does not hamper the movement of myosin VIIA forced dimer to the tip of filopodia (Fig. S4B) . In contrast, the SAH domain is important to achieve the movement of myosin VIIA to the filopodial tips (Fig. S4B) . It was shown for myosin Va that the shortening of the IQ domain diminishes the run length of myosin Va, suggesting that the length of IQ domain is important for processive movement of myosin Va (20, 22) . Previously, we found that the deletion of the SAH region hampered the continuous movement of dimerized myosin X (12) . Therefore, it is thought that the SAH region provides the sufficient length/flexibility of the neck to achieve continuous movement of dimerized myosin.
It was shown previously with melanophilin-depleted skin melanocytes that myosin VIIA overexpression alone failed to rescue the melanosome clustering phenotype, whereas coexpression of MyRip and myosin VIIA restored normal peripheral melanosome distribution (41) . The present results are consistent with this earlier report. The presence of both myosin VIIA and MyRip are critical to showing the myosin VIIA-dependent phenotype, further suggesting that MyRip not only is a cargo but also plays a role in the activation of myosin VIIA as a cargo-transporting motor. In RPE cells in retina, it was reported that myosin VIIA and melanosomes are not highly localized at the tip of apical process (10, 42) . The diameter of apical process is small compared with the elongated melanosomes in mature RPE cells (10) . It is known that the majority of melanosomes were located below the apical region of the RPE (43) , and it is thought that melanosomes below the apical process can absorb light effectively and completely, blocking the light coming from all directions. The distribution of melanosomes of the RPE at this location is very important to proper optical function. The present finding is consistent with the idea that myosin VIIA transports melanosomes to the base of apical process and localizes them to absorb light, which is critical for normal optical function.
Materials and Methods
Plasmid Construction. Myosin VIIA, MyRip, and Rab27a cDNAs were obtained from a human cDNA library, and the amino acid sequences were identical with the submitted sequences (GenBank accession nos. NM000260, NM015460, and BC136423). The FKBP-encoding fragment was PCR-amplified from pC4-Fv1E (ARIAD Pharmaceuticals) and subcloned into pEGFP-M7HMM to create pEGFP-M7HMM-FKBP. GFP-M7FullΔcoil-FKBP-tail was created by MELANOSOME MELANOSOME Values from three independent experiments are represented as mean ± SD. GFP-M7Full + mCherry vector alone, 4.3 ± 1.0%, n = 688; GFP-M7Full + mCherry-MyRip, 56.0 ± 5.0%, n = 973; GFP-myosin VIIA ΔMyTHΔFERM + mCherry-MyRip, 11.9 ± 5.9%, n = 628; GFP-M7Full + mCherry-MyRipΔFyve, 15.9 ± 3.3%, n = 1,277; GFP-M7FullΔcoil + mCherry-MyRip, 49.0 ± 4.4%, n = 925. (E) Model that explains the cargo molecule-dependent regulation of myosin VIIA movement. Myosin VIIA bound to the adaptor molecules MyRip and Rab27a associates with membrane vesicles. On membrane vesicles, myosin VIIA monomers move laterally and encounter each other to form a cluster of molecules. When the molecules in the cluster come close enough to interact with each other, the two monomers form a dimer. Once myosin VIIA forms a cluster of molecules or a dimer, it carries the cargo to the filopodial tips.
swapping the FKBP fragment for the myosin VIIA coiled-coil domain (901-929 aa). pEGFP-M7FullΔcoil was generated by the PCR-mediated plasmid DNA deletion method. Myosin VIIA motor dead mutants (R212A and G457A) and Usher syndrome type 1B mutants (G25R) were created by site-directed mutagenesis (44) . The other deleted myosin VIIA constructs and MyRipΔFyve were generated by PCR methods using appropriate sets of primers with restriction enzyme site. All expression plasmids were verified by DNA sequencing.
Chemical Cross-Linking of Cellular Extracts. ARPE-19 cells were transfected with the indicated constructs on 10-cm dishes. At 24 h after the transfection, the cells were washed with PBS and collected in a 1.5-mL tube. The cell pellets were snap-frozen with liquid nitrogen and stored at −80°C. The cells were resuspended in 60 μL of Solution A [150 mM NaCl, 25 mM Hepes/NaOH (pH 7.4), 1 mM PMSF, 10 μg/mL leupeptin, 2 μg/mL pepstatin A, and 1 μg/mL trypsin inhibitor] and homogenized in a 1.5-mL tube with a pellet pestle (Kimble-Kontes) on ice. The samples were centrifuged at 22,000 × g for 5 min at 4°C, and the supernatants were mixed with an equal volume of Solution B [1050 mM NaCl, 25 mM Hepes/NaOH (pH 7.4), 1 mM PMSF, 10 μg/ mL leupeptin, 2 μg/mL pepstatin A, and 1 μg/mL trypsin inhibitor]. For the cross-linking of full-length myosin VIIA in ARPE-19 cells, 5 mM ATP and 0.5% Nonidet P-40 were added to Solutions A and B. After 1 min, the samples were incubated with 50 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC; Invitrogen) ( Fig. 1 A-C) or with 15 mM EDC and 15 mM sulfo-NHS (Invitrogen) (Fig. 4D) at 25°C. At the indicated time, the aliquots were immediately mixed with 1/2 vol of 0.1 M Tris containing SDS sample buffer [0.1 M Tris·HCl (pH 6.8), 4% SDS, 60% glycerol, 0.04% bromophenol blue, and 100 mM DTT] to stop the reaction. Proteins were separated on a 3.75% Weber-Osborn SDS/phosphate gels.
Further details on antibodies, Western blot analysis, cell culture and transfection, confocal microscopy, immunofluorescence staining, and subcellular fractionation are available in SI Materials and Methods.
